Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Improved Breast Cancer Survival Following Introduction of an Organized Mammography Screening Program
Link ID 18914
Title Improved Breast Cancer Survival Following Introduction of an Organized Mammography Screening Program
Url http://www.medscape.com/viewarticle/708441?src=rss
Description This study investigated whether mammography screening is associated with optimized treatment and improved survival through multidisciplinary medical care. Breast Cancer Research
Category Articles > Hematology-Oncology
Keywords
Date Sep 29, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeo
  Variation in margin status and treatment patterns by surgeon are examined. How might diagnosis/treatment discrepancies affect health outcomes? Journal of the National Cancer Institute
Category:   Articles > Hematology-Oncology


2. The Use of Both Antegrade and Retrograde Internal Mammary Vessels in a Folded, Stacked Deep Inferior
  The authors describe an autologoud ps breast reconstruction with a deep inferior epigastric artery perforatorled DIEP flap for a female patient with recurrent ductal carcinoma in situ. ePlasty, Open Access Journal of Plastic Surgery
Category:   Articles > Hematology-Oncology


3. Lenalidomide Has Positive Benefit/Risk Ratio, Says EMALenalidomide Has Positive Benefit/Risk Ratio,
  The benefit/risk balance for lenalidomide remains positive within its approved population, according to the European Medicines Agency (EMA). Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Chemo Toxicity May Tip Scales in Advanced Hodgkins LymphomaChemo Toxicity May Tip Scales in Advanced
  Overall survival nearly evened out in a clinical trial comparing 2 chemotherapy regimens; adverse events might be a deciding factor in choosing one or the other. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


5. ASH 2008: Imatinib Can Be Discontinued in Some Patients With CML
  Imatinib therapy can be discontinued in patients with chronic myeloid leukemia who experience a complete molecular response; it does not automatically lead to relapse. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS